<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2011//EN" "http://www.ncbi.nlm.nih.gov/entrez/query/DTD/pubmed_110101.dtd">
<pubmedarticleset>
 <pubmedarticle>
  <medlinecitation owner="NLM" status="MEDLINE">
   <pmid version="1">
    15550401
   </pmid>
   <datecreated>
    <year>
     2004
    </year>
    <month>
     12
    </month>
    <day>
     13
    </day>
   </datecreated>
   <datecompleted>
    <year>
     2004
    </year>
    <month>
     12
    </month>
    <day>
     27
    </day>
   </datecompleted>
   <daterevised>
    <year>
     2009
    </year>
    <month>
     11
    </month>
    <day>
     18
    </day>
   </daterevised>
   <article pubmodel="Print-Electronic">
    <journal>
     <issn issntype="Electronic">
      1468-5833
     </issn>
     <journalissue citedmedium="Internet">
      <volume>
       329
      </volume>
      <issue>
       7479
      </issue>
      <pubdate>
       <year>
        2004
       </year>
       <month>
        Dec
       </month>
       <day>
        11
       </day>
      </pubdate>
     </journalissue>
     <title>
      BMJ (Clinical research ed.)
     </title>
     <isoabbreviation>
      BMJ
     </isoabbreviation>
    </journal>
    <articletitle>
     Parenteral metoclopramide for acute migraine: meta-analysis of randomised controlled trials.
    </articletitle>
    <pagination>
     <medlinepgn>
      1369-73
     </medlinepgn>
    </pagination>
    <abstract>
     <abstracttext label="OBJECTIVE" nlmcategory="OBJECTIVE">
      To assess the evidence from controlled trials on the efficacy and tolerability of parenteral metoclopramide for acute migraine in adults.
     </abstracttext>
     <abstracttext label="DATA SOURCES" nlmcategory="METHODS">
      Cochrane Central Register of Controlled Trials, Medline, Embase, LILACS, CINAHL, conference proceedings, clinical practice guidelines, and other sources.
     </abstracttext>
     <abstracttext label="SELECTION CRITERIA" nlmcategory="METHODS">
      Randomised controlled trials of parenteral metoclopramide for acute migraine in adults.
     </abstracttext>
     <abstracttext label="RESULTS" nlmcategory="RESULTS">
      We reviewed 596 potentially relevant abstracts and found 13 eligible trials totalling 655 adults. In studies comparing metoclopramide with placebo, metoclopramide was more likely to provide significant reduction in migraine pain (odds ratio 2.84, 95% confidence interval 1.05 to 7.68). Used as the only agent, metoclopramide showed mixed effectiveness when compared with other single agents. Heterogeneity of studies for combination treatment prevented statistical pooling. Treatments that did include metoclopramide were as, or more, effective than comparison treatments for pain, nausea, and relapse outcomes reported in all studies.
     </abstracttext>
     <abstracttext label="CONCLUSIONS" nlmcategory="CONCLUSIONS">
      Metoclopramide is an effective treatment for migraine headache and may be effective when combined with other treatments. Given its non-narcotic and antiemetic properties, metoclopramide should be considered a primary agent in the treatment of acute migraines in emergency departments.
     </abstracttext>
    </abstract>
    <affiliation>
     Department of Psychiatry, University of Cambridge, Cambridge CB2 2QQ.
    </affiliation>
    <authorlist completeyn="Y">
     <author validyn="Y">
      <lastname>
       Colman
      </lastname>
      <forename>
       Ian
      </forename>
      <initials>
       I
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Brown
      </lastname>
      <forename>
       Michael D
      </forename>
      <initials>
       MD
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Innes
      </lastname>
      <forename>
       Grant D
      </forename>
      <initials>
       GD
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Grafstein
      </lastname>
      <forename>
       Eric
      </forename>
      <initials>
       E
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Roberts
      </lastname>
      <forename>
       Ted E
      </forename>
      <initials>
       TE
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Rowe
      </lastname>
      <forename>
       Brian H
      </forename>
      <initials>
       BH
      </initials>
     </author>
    </authorlist>
    <language>
     eng
    </language>
    <publicationtypelist>
     <publicationtype>
      Journal Article
     </publicationtype>
     <publicationtype>
      Meta-Analysis
     </publicationtype>
     <publicationtype>
      Research Support, Non-U.S. Gov't
     </publicationtype>
    </publicationtypelist>
    <articledate datetype="Electronic">
     <year>
      2004
     </year>
     <month>
      11
     </month>
     <day>
      18
     </day>
    </articledate>
   </article>
   <medlinejournalinfo>
    <country>
     England
    </country>
    <medlineta>
     BMJ
    </medlineta>
    <nlmuniqueid>
     8900488
    </nlmuniqueid>
    <issnlinking>
     0959-535X
    </issnlinking>
   </medlinejournalinfo>
   <chemicallist>
    <chemical>
     <registrynumber>
      0
     </registrynumber>
     <nameofsubstance>
      Antiemetics
     </nameofsubstance>
    </chemical>
    <chemical>
     <registrynumber>
      364-62-5
     </registrynumber>
     <nameofsubstance>
      Metoclopramide
     </nameofsubstance>
    </chemical>
   </chemicallist>
   <citationsubset>
    AIM
   </citationsubset>
   <citationsubset>
    IM
   </citationsubset>
   <commentscorrectionslist>
    <commentscorrections reftype="Cites">
     <refsource>
      Arch Intern Med. 1999 Apr 26;159(8):813-8
     </refsource>
     <pmid version="1">
      10219926
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      CMAJ. 1997 May 1;156(9):1273-87
     </refsource>
     <pmid version="1">
      9145054
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Neurology. 2000 Sep 26;55(6):754-62
     </refsource>
     <pmid version="1">
      10993991
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Cephalalgia. 2000 Nov;20(9):765-86
     </refsource>
     <pmid version="1">
      11167908
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Headache. 2001 Nov-Dec;41(10):976-80
     </refsource>
     <pmid version="1">
      11903525
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Headache. 1991 Sep;31(8):523-4
     </refsource>
     <pmid version="1">
      1960056
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Ann Emerg Med. 1990 Oct;19(10):1083-7
     </refsource>
     <pmid version="1">
      2221512
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Neurology. 1989 Apr;39(4):590-2
     </refsource>
     <pmid version="1">
      2648190
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Med J Aust. 1986 Mar 31;144(7):366-9
     </refsource>
     <pmid version="1">
      3515136
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      J Neurol Neurosurg Psychiatry. 1980 Apr;43(4):369-71
     </refsource>
     <pmid version="1">
      7373338
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Ann Emerg Med. 1995 Nov;26(5):541-6
     </refsource>
     <pmid version="1">
      7486359
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      BMJ. 1994 Nov 12;309(6964):1286-91
     </refsource>
     <pmid version="1">
      7718048
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Headache. 1995 May;35(5):256-9
     </refsource>
     <pmid version="1">
      7775186
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Headache. 1994 Jul-Aug;34(7):439-41
     </refsource>
     <pmid version="1">
      7928330
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Headache. 1993 Nov-Dec;33(10):560-2
     </refsource>
     <pmid version="1">
      8294195
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Can J Neurol Sci. 1993 May;20(2):131-7
     </refsource>
     <pmid version="1">
      8334575
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Ann Emerg Med. 1993 Feb;22(2):191-5
     </refsource>
     <pmid version="1">
      8427430
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Acad Emerg Med. 1995 Jul;2(7):597-602
     </refsource>
     <pmid version="1">
      8521205
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Am J Emerg Med. 1996 May;14(3):262-4
     </refsource>
     <pmid version="1">
      8639197
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Control Clin Trials. 1996 Feb;17(1):1-12
     </refsource>
     <pmid version="1">
      8721797
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="CommentIn">
     <refsource>
      ACP J Club. 2005 May-Jun;142(3):77
     </refsource>
     <pmid version="1">
      15862076
     </pmid>
    </commentscorrections>
   </commentscorrectionslist>
   <meshheadinglist>
    <meshheading>
     <descriptorname majortopicyn="N">
      Adult
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Antiemetics
     </descriptorname>
     <qualifiername majortopicyn="Y">
      administration &amp; dosage
     </qualifiername>
     <qualifiername majortopicyn="N">
      adverse effects
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Humans
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Infusions, Parenteral
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Metoclopramide
     </descriptorname>
     <qualifiername majortopicyn="Y">
      administration &amp; dosage
     </qualifiername>
     <qualifiername majortopicyn="N">
      adverse effects
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Migraine Disorders
     </descriptorname>
     <qualifiername majortopicyn="Y">
      drug therapy
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Randomized Controlled Trials as Topic
     </descriptorname>
     <qualifiername majortopicyn="N">
      standards
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Treatment Outcome
     </descriptorname>
    </meshheading>
   </meshheadinglist>
   <otherid source="NLM">
    PMC535449
   </otherid>
  </medlinecitation>
  <pubmeddata>
   <history>
    <pubmedpubdate pubstatus="aheadofprint">
     <year>
      2004
     </year>
     <month>
      November
     </month>
     <day>
      18
     </day>
    </pubmedpubdate>
    <pubmedpubdate pubstatus="pubmed">
     <year>
      2004
     </year>
     <month>
      11
     </month>
     <day>
      20
     </day>
     <hour>
      9
     </hour>
     <minute>
      0
     </minute>
    </pubmedpubdate>
    <pubmedpubdate pubstatus="medline">
     <year>
      2004
     </year>
     <month>
      12
     </month>
     <day>
      28
     </day>
     <hour>
      9
     </hour>
     <minute>
      0
     </minute>
    </pubmedpubdate>
    <pubmedpubdate pubstatus="entrez">
     <year>
      2004
     </year>
     <month>
      11
     </month>
     <day>
      20
     </day>
     <hour>
      9
     </hour>
     <minute>
      0
     </minute>
    </pubmedpubdate>
   </history>
   <publicationstatus>
    ppublish
   </publicationstatus>
   <articleidlist>
    <articleid idtype="pii">
     bmj.38281.595718.7C
    </articleid>
    <articleid idtype="doi">
     10.1136/bmj.38281.595718.7C
    </articleid>
    <articleid idtype="pubmed">
     15550401
    </articleid>
    <articleid idtype="pmc">
     PMC535449
    </articleid>
   </articleidlist>
  </pubmeddata>
 </pubmedarticle>
</pubmedarticleset>

